Search

Louise Wang Zhiying Humphrey

Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )

Most Active Art Unit
1648
Art Unit(s)
1657, 1648
Total Applications
627
Issued Applications
267
Pending Applications
54
Abandoned Applications
312

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4898880 [patent_doc_number] => 20080118494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Compositions For Detection Of Latent Hiv Reactivation And Methods Of Using The Same' [patent_app_type] => utility [patent_app_number] => 11/661881 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21096 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118494.pdf [firstpage_image] =>[orig_patent_app_number] => 11661881 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/661881
Compositions For Detection Of Latent Hiv Reactivation And Methods Of Using The Same Sep 1, 2005 Abandoned
Array ( [id] => 5743133 [patent_doc_number] => 20060088858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Modified venom and venom components as anti-retroviral agents' [patent_app_type] => utility [patent_app_number] => 11/217713 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7301 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088858.pdf [firstpage_image] =>[orig_patent_app_number] => 11217713 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/217713
Modified venom and venom components as anti-retroviral agents Sep 1, 2005 Abandoned
Array ( [id] => 4859150 [patent_doc_number] => 20080268000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Vaccine Stabilising Formula with Live Antigens for Use in Mass Vaccination Systems' [patent_app_type] => utility [patent_app_number] => 12/065216 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5971 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20080268000.pdf [firstpage_image] =>[orig_patent_app_number] => 12065216 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/065216
Vaccine Stabilising Formula with Live Antigens for Use in Mass Vaccination Systems Aug 31, 2005 Abandoned
Array ( [id] => 5726860 [patent_doc_number] => 20060057620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Treatment of HIV infection' [patent_app_type] => utility [patent_app_number] => 11/212906 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3845 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057620.pdf [firstpage_image] =>[orig_patent_app_number] => 11212906 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/212906
Treatment of HIV infection Aug 28, 2005 Abandoned
Array ( [id] => 5533042 [patent_doc_number] => 20090232830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Modified HIV-1 Envelope Proteins' [patent_app_type] => utility [patent_app_number] => 11/661210 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17248 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232830.pdf [firstpage_image] =>[orig_patent_app_number] => 11661210 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/661210
Modified HIV-1 envelope proteins Aug 28, 2005 Issued
Array ( [id] => 5125512 [patent_doc_number] => 20070237783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV' [patent_app_type] => utility [patent_app_number] => 11/211576 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7168 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20070237783.pdf [firstpage_image] =>[orig_patent_app_number] => 11211576 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/211576
Modified HIV peptides, antigens, compositions, immunoassay kit and a method of detecting antibodies induced by HIV Aug 25, 2005 Issued
Array ( [id] => 5902489 [patent_doc_number] => 20060045886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'HIV immunostimulatory compositions' [patent_app_type] => utility [patent_app_number] => 11/213405 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8161 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20060045886.pdf [firstpage_image] =>[orig_patent_app_number] => 11213405 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213405
HIV immunostimulatory compositions Aug 25, 2005 Abandoned
Array ( [id] => 5902488 [patent_doc_number] => 20060045885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Method of eliciting an immune response against HIV' [patent_app_type] => utility [patent_app_number] => 11/213354 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8222 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20060045885.pdf [firstpage_image] =>[orig_patent_app_number] => 11213354 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/213354
Method of eliciting an immune response against HIV Aug 25, 2005 Abandoned
Array ( [id] => 5563627 [patent_doc_number] => 20090136479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Ubiquitin-like protein isg15 for hiv inhibition' [patent_app_type] => utility [patent_app_number] => 11/630544 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10854 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136479.pdf [firstpage_image] =>[orig_patent_app_number] => 11630544 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630544
Ubiquitin-like protein isg15 for hiv inhibition Jun 27, 2005 Abandoned
Array ( [id] => 4959709 [patent_doc_number] => 20080274134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex' [patent_app_type] => utility [patent_app_number] => 11/629843 [patent_app_country] => US [patent_app_date] => 2005-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 44848 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274134.pdf [firstpage_image] =>[orig_patent_app_number] => 11629843 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629843
Hiv-1 Neutralizing Antibodies Elicited By Trimeric Hiv-1 Envelope Glycoprotein Complex Jun 14, 2005 Abandoned
Array ( [id] => 5887720 [patent_doc_number] => 20060275321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Polypeptide antagonists of HIV-1 Tat protein' [patent_app_type] => utility [patent_app_number] => 11/143550 [patent_app_country] => US [patent_app_date] => 2005-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7711 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275321.pdf [firstpage_image] =>[orig_patent_app_number] => 11143550 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/143550
Polypeptide antagonists of HIV-1 Tat protein May 31, 2005 Abandoned
Array ( [id] => 5800122 [patent_doc_number] => 20060035249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS' [patent_app_type] => utility [patent_app_number] => 11/140311 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 44601 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035249.pdf [firstpage_image] =>[orig_patent_app_number] => 11140311 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/140311
Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS May 26, 2005 Abandoned
Array ( [id] => 5440918 [patent_doc_number] => 20090092557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'GRIFFITHSIN, GLYCOSYLATION-RESISTANT GRIFFITHSIN, AND RELATED CONJUGATES, COMPOSITIONS, NUCLEIC ACIDS, VECTORS, HOST CELLS, METHODS OF PRODUCTION AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 11/569813 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26336 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092557.pdf [firstpage_image] =>[orig_patent_app_number] => 11569813 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569813
Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use May 26, 2005 Issued
Array ( [id] => 6100862 [patent_doc_number] => 20110004951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'METHODS AND COMPOSITIONS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV-1 SUBUNIT-SPECIFIC REVERSE TRANSCRIPTASE' [patent_app_type] => utility [patent_app_number] => 10/599851 [patent_app_country] => US [patent_app_date] => 2005-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 27366 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20110004951.pdf [firstpage_image] =>[orig_patent_app_number] => 10599851 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599851
METHODS AND COMPOSITIONS FOR IDENTIFYING COMPOUNDS THAT INHIBIT HIV-1 SUBUNIT-SPECIFIC REVERSE TRANSCRIPTASE May 23, 2005 Abandoned
Array ( [id] => 4873816 [patent_doc_number] => 20080200550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein' [patent_app_type] => utility [patent_app_number] => 11/597431 [patent_app_country] => US [patent_app_date] => 2005-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 39944 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200550.pdf [firstpage_image] =>[orig_patent_app_number] => 11597431 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597431
Inhibition of Hiv-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein May 23, 2005 Abandoned
Array ( [id] => 7110594 [patent_doc_number] => 20050208049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy' [patent_app_type] => utility [patent_app_number] => 11/131687 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6475 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208049.pdf [firstpage_image] =>[orig_patent_app_number] => 11131687 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/131687
Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy May 16, 2005 Abandoned
Array ( [id] => 5894412 [patent_doc_number] => 20060002951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Inhibition of the tRNALys3-primed initiation of reverse transcription in HIV-1 by APOBEC3G' [patent_app_type] => utility [patent_app_number] => 11/129442 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25202 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002951.pdf [firstpage_image] =>[orig_patent_app_number] => 11129442 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/129442
Inhibition of the tRNALys3-primed initiation of reverse transcription in HIV-1 by APOBEC3G May 15, 2005 Abandoned
Array ( [id] => 7110617 [patent_doc_number] => 20050208072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Preventive and therapeutic aids vaccines' [patent_app_type] => utility [patent_app_number] => 11/126498 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11962 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208072.pdf [firstpage_image] =>[orig_patent_app_number] => 11126498 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/126498
Preventive and therapeutic aids vaccines May 9, 2005 Abandoned
Array ( [id] => 211219 [patent_doc_number] => 07622125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Polycistronic HIV vector constructs' [patent_app_type] => utility [patent_app_number] => 11/124602 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 27519 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622125.pdf [firstpage_image] =>[orig_patent_app_number] => 11124602 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/124602
Polycistronic HIV vector constructs May 4, 2005 Issued
Array ( [id] => 5808507 [patent_doc_number] => 20060094862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Specificity exchangers that redirect antibodies to a pathogen' [patent_app_type] => utility [patent_app_number] => 11/121282 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21090 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094862.pdf [firstpage_image] =>[orig_patent_app_number] => 11121282 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/121282
Specificity exchangers that redirect antibodies to a pathogen May 2, 2005 Abandoned
Menu